# The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover

> **NCT04859322** · NA · COMPLETED · sponsor: **Malte Palm Suppli, MD** · enrollment: 20 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Glucagon Resistance

## Interventions

- **DRUG:** Glucagon

## Key facts

- **NCT ID:** NCT04859322
- **Lead sponsor:** Malte Palm Suppli, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2021-12-09
- **Final completion:** 2021-12-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04859322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04859322, "The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04859322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*